News - Giza Venture Capital
CAESAREA, Israel, May 25, 2011 /PRNewswire/ -- LifeBond, a biosurgery device company, announced today that it has completed a $20m C financing round, led by Giza Venture Capital and Morris Kahn's Aurum Ventures. Existing investors Pitango Venture Capital, Mr.
TEL AVIV, Israel, Nov. 23 /PRNewswire/ -- WinBuyer, the leader in the growing market for Onsite Comparative Pricing (OCP) applications announced today the completion of a $6.9 Million first round investment led by Pitango Venture Capital alongside Giza Venture Capital.
BioLineRx, Israel's leading specialized drug development company, today announced that current investors Giza Venture Capital, Pitango Venture Capital and Teva Pharmaceuticals Industries Ltd. have committed an additional $9 million in funding to the company.